119th Congress · introduced in the House · Feb 13, 2025
Women’s Protection in Telehealth Act
Official title from Congress.gov
Latest action (Feb 13, 2025): Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in House (Feb 13, 2025)
Women’s Protection in Telehealth Act
This bill excludes providers of abortion-inducing drugs from participating in Medicare unless the provider is a physician who physically examines the patient, is physically present when the drug is administered, and schedules an in-person follow-up visit with the patient within 14 days of administering the drug.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Abortion · Computers and information technology · Drug therapy · Health care coverage and access · Health technology, devices, supplies · Medicare · Prescription drugs · Women's health
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
10 citations.
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Family issues/Abortion/Adoption
$310,000
Spent on own lobbying
…h Insurance (EACH) Act H.R.682 - Heartbeat Protection Act of 2025 H.R.589 - FACE Act Repeal Act of 2025 H.R.632 - Protecting Life on College Campus Act of 2025 H.R.1349 - Womens Protection in Telehealth Act H.R.8784 - Bereaved Parents Rights Act H.R.722 - Life at Conception Act H.R.629 - Ending Chemical Abortions Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$310,000
Spent on own lobbying
…h Insurance (EACH) Act H.R.682 - Heartbeat Protection Act of 2025 H.R.589 - FACE Act Repeal Act of 2025 H.R.632 - Protecting Life on College Campus Act of 2025 H.R.1349 - Womens Protection in Telehealth Act H.R.8784 - Bereaved Parents Rights Act H.R.722 - Life at Conception Act H.R.629 - Ending Chemical Abortions Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Pharmacy
$310,000
Spent on own lobbying
…gs S.3697, H.R.685 - SAVE Moms and Babies Act of 2026 S.2955, H.R.6466 - Forced Abortion Prevention and Accountability Act H.R.5485 - Second Chance at Life Act H.R. 1349 - Womens Protection in Telehealth Act H.R.629- Ending Chemical Abortions Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$420,000
Spent on own lobbying
…mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 795 Pregnancy Is Not an Illness Act; H.R. 796 Second Chance for Moms Act; H.R. 1349 Womens Protection in Telehealth Act; H.R. 1525 Protecting Life from Chemical Abortions Act; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Family issues/Abortion/Adoption
$420,000
Spent on own lobbying
…mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 795 Pregnancy Is Not an Illness Act; H.R. 796 Second Chance for Moms Act; H.R. 1349 Womens Protection in Telehealth Act; H.R. 1525 Protecting Life from Chemical Abortions Act; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Pharmacy
$420,000
Spent on own lobbying
…mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 795 Pregnancy Is Not an Illness Act; H.R. 796 Second Chance for Moms Act; H.R. 1349 Womens Protection in Telehealth Act; H.R. 1525 Protecting Life from Chemical Abortions Act; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$420,000
Spent on own lobbying
…by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 1349 Womens Protection in Telehealth Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; Presidential Administration Actions; H.R. 6372 D.C. Shield La…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 17, 2025 · issue area: Medical/Disease Research/Clinical Labs
$600,000
Spent on own lobbying
…Expectant Moms and Babies Act; Emergency Medical Treatment and Active Labor Act; HOPE with Fertility Services Act; Dismemberment Abortion Ban Act; IVF Issues; H.R.1349 Womens Protection in Telehealth Act; Budget Reconciliation; Administration Personnel; Presidential Administration Actions; Abortion Ballot Measures; Late-term…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 17, 2025 · issue area: Family issues/Abortion/Adoption
$600,000
Spent on own lobbying
…isk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 599, S.177 Protect Funding for Women's Health Care Act; H.R.1349 Womens Protection in Telehealth Act; S.242 Dignity for Aborted Children Act; H.R.2644 Love Them Both Act; H.R.2282, S.535 Respect Parents Childcare Choices Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 17, 2025 · issue area: Health Issues
$600,000
Spent on own lobbying
…isk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 599, S.177 Protect Funding for Women's Health Care Act; H.R.1349 Womens Protection in Telehealth Act; S.242Dignity for Aborted Children Act; H.R.2226 Let Pregnancy Centers Serve Act of 2025; H.J.Res.82 Disapproving the actio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing